Antitumor cell activity in vitro by myristoylated-peptide

Biomedicine and Pharmacotherapy

Volumn 65, Issue 4, 2011, Pages 271-274

  Ourth, Donald D ^a  

^a University of Memphis   (United States)

Author keywords

Antitumor cell activity; Myristoylated peptide

Indexed keywords

ANTINEOPLASTIC AGENT; N MYRISTOYLATED PEPTIDE; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; FIBROBLAST; HELIOTHIS VIRESCENS; HEMOLYMPH; HUMAN; HUMAN CELL; IN VITRO STUDY; INSECT; KIDNEY CANCER; LARVA; LEUKEMIA; LUNG NON SMALL CELL CANCER; MELANOMA; MYRISTYLATION; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FIBROBLASTS; HEMOLYMPH; HUMANS; LIPOPEPTIDES; MOTHS;

EID: 79960384535     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.02.015     Document Type: Article

References (12)

1. Garcia M., Jemal A., Ward E.M., Center M.M., Hao Y. Global cancer facts and figures 2007, American Cancer Society, Atlanta, GA, 46 pp.
2. Ledford H. Prevention by numbers. Nature 2009, 458:792-793.
3. Weinberg RA. The biology of cancer. Garland Sci 2006;850 pp.
4. Ourth D.D. Antiviral activity against human immunodeficiency virus-1 in vitro by myristoylated-peptide from Heliothis virescens. Biochem Biophys Res Comm 2004, 320:190-196.
5. Ourth D.D. Susceptibility in vitro of Epstein-Barr virus to myristoylated-peptide. Peptides 2010, 31:1409-1411.
6. Ourth D.D., Renis H.E. Antiviral melanization reaction of Heliothis virescens hemolymph against DNA and RNA viruses in vitro. Comp Biochem Physiol 1993, 105B:719-723.
7. Grever M.R., Schepartz S.A., Chabner B.A. The National Cancer Institute: cancer drug discovery and development program. Semin Oncol 1992, 19:622-638.
8. Boyd M.R., Paull K.D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Develop Res 1995, 34:91-109.
9. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988, 48:589-601.
10. Shoemaker R.H. The NCI60 human tumor cell line anticancer drug screen. Nat Rev Cancer 2006, 6:813-823.
11. Farazi T.A., Waksman G., Gordon J.I. The biology and enzymology of protein N-myristoylation. J Biol Chem 2001, 276:39501-39504.
12. Beare-Rogers J., Dieffenbacher A., Holm J.V. Lexicon of lipid nutrition. Pure Appl Chem 2001, 73:685-744.